(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2026-01-12 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 1227591
| Date | Daily Closing Price | Open | High | Low | Volume |
| 12 Mon Jan 2026 | 4.50 | 4.59 | 4.59 | 4.39 | 0.823 times |
| 09 Fri Jan 2026 | 4.62 | 4.69 | 4.73 | 4.59 | 0.735 times |
| 08 Thu Jan 2026 | 4.65 | 4.81 | 4.87 | 4.59 | 1.116 times |
| 07 Wed Jan 2026 | 4.88 | 4.81 | 5.00 | 4.79 | 1.281 times |
| 06 Tue Jan 2026 | 4.79 | 4.75 | 4.83 | 4.65 | 0.708 times |
| 05 Mon Jan 2026 | 4.71 | 4.77 | 4.84 | 4.66 | 0.652 times |
| 02 Fri Jan 2026 | 4.77 | 4.86 | 4.98 | 4.65 | 1.313 times |
| 31 Wed Dec 2025 | 4.81 | 4.61 | 5.05 | 4.59 | 2.501 times |
| 30 Tue Dec 2025 | 4.62 | 4.70 | 4.75 | 4.55 | 0.766 times |
| 29 Mon Dec 2025 | 4.72 | 4.76 | 4.81 | 4.66 | 0.442 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 4.6, but if it comes above 4.6, then a intra day buy could be more profitable.
If you take a sell trade below 4.6, then use 4.6 as stoploss and 4.4 as target. However if you take a buy trade in stock , then use 4.6 as stoploss and 4.7 as target.
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 3.66 |
| Downside Target | 4.08 |
| Downside Target | 4.39 |
| Upside Target | 4.55 |
| Upside Target | 4.87 |
| Upside Target | 4.95 |
| Upside Target | 5.00 |
| Upside Target | 5.05 |
| Upside Target | 5.07 |
| Upside Target | 5.10 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 4.4 |
| Downside Intraday Target | 4.29 |
| Upside Intraday Target | 4.6 |
| Upside Intraday Target | 4.69 |
| Downside Intraday Target | 4.49 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 12 Mon Jan 2026 | 4.50 | 4.59 | 4.59 | 4.39 | 0.183 times |
| 09 Fri Jan 2026 | 4.62 | 4.77 | 5.00 | 4.59 | 0.894 times |
| 02 Fri Jan 2026 | 4.77 | 4.76 | 5.05 | 4.55 | 1.806 times |
| 26 Fri Dec 2025 | 4.78 | 4.46 | 4.91 | 4.45 | 0.327 times |
| 19 Fri Dec 2025 | 4.43 | 4.72 | 5.07 | 4.42 | 1.934 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 12 Mon Jan 2026 | 4.50 | 4.86 | 5.00 | 4.39 | 0.283 times |
| 31 Wed Dec 2025 | 4.81 | 4.34 | 5.07 | 4.09 | 1.487 times |
| 28 Fri Nov 2025 | 4.41 | 4.51 | 4.87 | 4.08 | 0.863 times |
| 31 Fri Oct 2025 | 4.73 | 4.55 | 4.95 | 4.10 | 0.669 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.73 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.73 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.